“Accusations abound that the medical debate is something of a Trojan horse for multinationals jostling over future control of the UK’s £multibillion illicit cannabis market,” The Observer writes of this week’s Cannabis Europa conference.
“Accusations abound that the medical debate is something of a Trojan horse for multinationals jostling over future control of the UK’s £multibillion illicit cannabis market,” The Observer writes of this week’s Cannabis Europa conference.